Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathway
- PMID: 39544904
- PMCID: PMC11559522
- DOI: 10.1177/23971983241269109
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathway
Abstract
Objective: To optimise the organisation of care and encourage the adoption of good clinical practices, the RarERN Path© methodology was designed within ERN ReCONNET. The aim of our work was to report the application of RarERN Path© on systemic sclerosis within the ERN ReCONNET centres, providing a feasible and flexible organisational reference model for optimising the systemic sclerosis care pathway in different countries.
Methods: RarERN Path© is a six-phase methodology which enables the creation of a reference organisational model co-designed on the basis of the expertise of different stakeholders. It foresees six phases, ranging from the map of existing patients' care pathways and patients' stories, to the consensus on a common organisational patient care pathways, and its key performance indicators definition.
Results: The agreed reference model highlights the importance of having an organisational flow for referrals that foresees how patients may access directly the specialised unit from the different referrals. Specific specialised visits were considered as mandatory to be organised and they included cardiologist, pneumologist, gastroenterologist, psychologist, nephrologist, dermatologist, wound care specialist/nurses and other healthcare professionals (such as nurses, social workers and nutritional counselling). Moreover, specific services related to therapy were highlighted as strongly recommended to be organised, mainly represented by infusion therapy and wound care, as well as occupation therapy and physiotherapy.
Conclusion: The organisational model emerged from our investigation emphasises that the organisation of specific services for systemic sclerosis treatment should be organised as a solid support for implementing the existing recommendations on systemic sclerosis management in real life.
Keywords: European Commission; European Reference Networks; RarERN Path©; organisation of care; organisational reference model; patients’ care pathways; systemic sclerosis.
© The Author(s) 2024.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Figures
References
-
- Benvenuti F, Zanatta E, Avouac J, et al.. The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patients. Expert Rev Clin Immunol 2020; 16(11): 1065–1074. - PubMed
-
- Varga J, Trojanowska M, Kuwana M, et al.. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. J Scleroderma Relat Disord 2017; 2(3): 137–152.
-
- Cutolo M, Smith V. Detection of microvascular changes in systemic sclerosis and other rheumatic diseases. Nat Rev Rheumatol 2021; 17(11): 665–677. - PubMed
-
- Vanhaecke A, Debusschere C, Cutolo M, et al.. Predictive value of laser speckle contrast analysis in systemic sclerosis. Eur J Clin Invest 2022; 52(1): e13672. - PubMed
LinkOut - more resources
Full Text Sources